Stomach cancer
Results
Phase 2/3
This trial compared trastuzumab emtansine with taxane chemotherapy for cancer of the stomach or cancer where the stomach meets the oesophagus. It was for people whose cancer cells have large amounts of a protein called HER2 (HER2 positive cancer) and had spread.
Recruitment start: 3 September 2012
Recruitment end: 30 June 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Was Mansoor
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Roche
Last reviewed: 22 July 2018
CRUK internal database number: 9724